LDS/Medical Tests/Immunoglobulin G (IgG)

Immunoglobulin G (IgG)

Immunoglobulin G (IgG) is a major circulating immunoglobulin and it represents almost 80% of the total immunoglobulins in our body. It exists in four subclasses: IgG1, IgG2, IgG3 and IgG4, with IgG1 being predominating at more than 65% of total IgG in our body. The classification of these subclasses is based on their heavy chains. However, change in the ratio or change in the level of one subclass can occur without change in the IgG total, and change in subclass levels is seen in different disorders and diseases. For example, decrease in IgG1 is seen in EBV infections, IgG2 in sinusitis and otitis media, and IgG3 with allergies, ataxia telangiectasia and respiratory infections. Significant decrease in IgG level, whether on a congenital or acquired basis, is associated with an increased susceptibility to infections. Thus, patient with repeated infection should check immunoglobulins and especially IgG as treatment with exogenous globulins might protect them from infection.

In contrast, IgG levels will be increased in immunocompetent patients responding to a wide variety of infections or inflammatory agents. However, the major cause for polyclonal increase is IgG is the acquired immunodeficiency syndrome. Oligoclonal IgG can occur in multiple sclerosis, and in some cases of chronic immune hepatitis.

Monoclonal IgG (M proteins) can be seen in more than 60% of cases in multiple myeloma. The levels can go as high as 40g/dL and 3g/dL of monoclonal IgG is a major diagnosis criteria for myeloma. However, M protein or monoclonal gammopathy can be presented in patients with the normal levels of total IgG. While these patients don’t have multiple myeloma, evaluation for such gammopathies and the presence of Bence Jones protein in urine would be significant. Differential diagnosis of multiple myeloma would differentiate multiple myeloma, including essential monoclonal gammopathy of undetermined significance (MGUS), which is characterized by lack of symptoms and lack of bone lesions, and monoclonal gammopathy with M protein <3.5g/dL.

Guidelines for evaluation of monoclonal gammopathy by the College of American Pathologist (CAP) recommends use of high resolution electrophoresis of serum and/or urine with reflex to immunofixation to define the abnormal protein. Immunofixation with kappa and lambda light chain antibody is recommended for detection of small M-proteins.

Decrease in IgG <300mg/dL with normal or increased IgM and IgD levels will lead to susceptibility to pyogenic and opportunistic infections. This condition is often inherited as an X-linked or autosomal recessive disease that occurs due to failure of activated T lymphocytes to activate B cells to proliferate and produce IgG antibody. IgG is the only immunoglobulin group that crosses the placenta, and maternal IgG will be protective as it provides passive immunity to neonates.

  • As an aid in diagnosis of multiple myeloma
  • As an aid in diagnosis and management of monoclonal gammopathies
  • As an aid in diagnosis of monoclonal gammopathy of undetermined significance
  • As an aid in management of patients with lymphoma and leukemia
  • As an aid in diagnosis and management of immune deficiencies
  • As an aid in diagnosis of autoimmune disorders
  • Monitor and manage chronic or recurrent infections

Increased in:

  • Chronic infection
  • Autoimmune disease
  • Rheumatoid arthritis
  • Autoimmune pancreatitis
  • Autoimmune hepatitis
  • Multiple myeloma
  • Solitary plasmocytoma
  • Gamma heavy chain disease
  • Monoclonal gammopathy of undetermined significance
  • Lymphoma
  • Chronic lymphocytic leukemia

Decreased in:

  • Primary immunodeficiency states
  • X-linked agammaglobulinemia
  • Hyper-IgM syndrome
  • Protein losing enteropathy
  • Treatment with immunosuppressants
  • Nephrotic syndrome
  • Thermal burns
  • Myotonic dystrophy
  • HIV infection
  • Other immunocompromised disorders

Adults: 565-1660 mg/dL

1 month: 250-900 mg/dL

2-5 months: 200-700 mg/dL

6-9 months: 200-900 mg/dL

10-12 moths: 290-1050 mg/dL

1-3 years: 350-1200 mg/dL

4-6 years: 450-1500 mg/dL

7-9 years: 650-1600 mg/dL

10-15 years: 700-1650 mg/dL

Nephelometry, Turbidometry, Enzyme Immunoassay, ELISA, Capillary Electrophoresis.

Serum (SST). 

Stability

  • Ambient: 5-7 days
  • Refrigerated: 7-14 days
  • Frozen: 1 month
Protein electrophoresis, Immunoelectrophoresis, IgG subclasses, IgM, Cryoglobulin.
1-3 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Liver Int. 2017 Apr 22. doi: 10.1111/liv.13458. [PMID: 28432836]
  • Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4541. [PMID: 28365915]
  • Clin Biochem. 2017 May 4. pii: S0009-9120(16)30742-1. [PMID: 28479151]
  • Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. [PMID: 25212882]
  • Ann Intern Med. 1971 Nov;75(5):673-82. [PMID: 5122154]
  • Am J Med. 1984 Mar 30;76(3A):7-18. [PMID: 6369977]
  • Am J Med. 1984 Mar 30;76(3A):1-6. [PMID: 6369973]
  • Crit Rev Clin Lab Sci. 1989;27(1):27-58. [PMID: 2647414]
  • Alan H.B Wu. Clinical Guide to Laboratory Tests, 4th ed. WB Saunders Company; 2006.
  • Fischbach FT, Dunning MB III, eds. Manual of Laboratory and Diagnostic Tests, 8th ed. Philadelphia: Lippincott Williams; 2009.